Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

34.25p
   
  • Change Today:
    -0.50p
  • 52 Week High: 48.10
  • 52 Week Low: 23.25
  • Currency: UK Pounds
  • Shares Issued: 361.48m
  • Volume: 709,100
  • Market Cap: £123.81m

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Christopher Paul Hancock 4,802,352 £1,644,806
Richard John Rees 2,805,902 £961,021
Craig Jonathan Gulliford 1,630,466 £558,435
John Bradshaw 1,371,082 £469,596
David Gerard Woods 440,255 £150,787
Charles Spicer 308,530 £105,672
Ivonne Cantu 125,000 £42,812

Major Shareholders

Notifier** Holding Value*
Canaccord Genuity Group Inc 39,303,064 £13,461,299
Development Bank of Wales plc 14,376,727 £4,924,029
Finance Wales 12,776,727 £4,376,029
Baillie Gifford & Co 12,537,441 £4,294,074
Creo Medical Group EBT 10,000,000 £3,425,000
M&G Investments 9,428,500 £3,229,261
The Capital Group Companies, Inc. 8,816,807 £3,019,756
AXA Framlington Investment Managers 7,992,961 £2,737,589
Hargreave Hale Limited 6,753,632 £2,313,119
Tellworth Investments 5,772,778 £1,977,176
Hoya Corporation 4,799,880 £1,643,959
Jonathan Craton 3,400,294 £1,164,601
Cotterford Co Limited 3,335,398 £1,142,374
Mark Farmer 3,121,607 £1,069,150
RBC Trustees (CI) Ltd 2,974,727 £1,018,844
Angel Co Fund 2,967,120 £1,016,239

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 34.25p
Change Today -0.50p
% Change -1.44 %
52 Week High 48.10
52 Week Low 23.25
Volume 709,100
Shares Issued 361.48m
Market Cap £123.81m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
20.24% below the market average20.24% below the market average20.24% below the market average20.24% below the market average20.24% below the market average
43.75% below the sector average43.75% below the sector average43.75% below the sector average43.75% below the sector average43.75% below the sector average
Price Trend
20.91% above the market average20.91% above the market average20.91% above the market average20.91% above the market average20.91% above the market average
45.95% above the sector average45.95% above the sector average45.95% above the sector average45.95% above the sector average45.95% above the sector average
Income Not Available
Growth
40.61% above the market average40.61% above the market average40.61% above the market average40.61% above the market average40.61% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
17:08 36,389 @ 34.25p
16:30 15,000 @ 34.38p
16:29 580 @ 34.45p
16:10 29,500 @ 34.50p
16:03 236,617 @ 33.51p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page